Hepatology · UK
Private assessment for liver transplant in the UK, alongside the NHS pathway.
The transplant itself is NHS-only and rightly so.
Indicative pricing
What private transplant assessment costs - and what it cannot buy.
The transplant operation itself is not on this list, because in the UK it cannot be bought at any price.
In short
A full private pre-referral work-up: £2,000–£4,000. The transplant itself: NHS only.
| Assessment step | Indicative range | Typical duration | Results |
|---|---|---|---|
| Consultant hepatologist opinion | £300–£500 | 45–60 min | Same visit |
| Full liver bloods + UKELD/MELD scoring | £250–£450 | 15 min | 2–5 days |
| Liver MRI or triple-phase CT | £700–£1,400 | 45 min | 48 hours |
| Echocardiogram + cardiology review | £500–£900 | 60 min | Same visit |
| Cardiopulmonary exercise testing (CPET) | £600–£1,000 | 60 min | 3–5 days |
| Transplant itself (NHS-designated centre) | NHS-funded | 6–12 hours | 2–4 weeks |
Under the Human Tissue Act 2004 it is a criminal offence to give or receive payment for an organ in the UK, and all liver transplantation takes place in the seven NHS-designated adult centres with organs allocated nationally by NHS Blood and Transplant. What private care genuinely buys is speed and certainty in the assessment that precedes referral.
The problem
The hard part is knowing whether you are close to needing one.
Most people with cirrhosis will never need a transplant. The judgement that matters is when the balance tips - and in the UK that judgement is made against specific, published criteria rather than by feel.
-
Not sure if you meet the criteria?
UKELD of 49 or above, or one of the recognised variant syndromes. A hepatologist can calculate exactly where you sit today.
-
Worried a referral is being delayed?
A private opinion, with a complete dataset attached, is often the fastest way to get a properly evidenced referral in front of a transplant centre.
-
Turned down and want it reviewed?
Decisions can be revisited if circumstances change - abstinence achieved, weight lost, cardiac risk treated. We help you understand what would need to change.
When it helps
When liver transplant assessment is the right step.
The situations that lead to referral, the ones managed without transplant, and the presentation that means an emergency rather than an appointment.
-
Decompensated cirrhosis
Ascites, variceal bleeding, hepatic encephalopathy or jaundice on a background of cirrhosis. Decompensation is the usual trigger for assessment.
-
UKELD score of 49 or above
The UK listing threshold, calculated from INR, creatinine, bilirubin and sodium. It corresponds to a one-year mortality without transplant of around nine per cent.
-
Hepatocellular carcinoma within criteria
HCC in a cirrhotic liver, within the UK listing criteria on size and number, where transplant treats both the tumour and the diseased liver.
-
Acute liver failure
Sudden liver failure from paracetamol overdose, viral hepatitis or drug injury. Assessed against the King’s College criteria as a super-urgent listing, in hours not weeks.
-
Recurrent cholangitis in PSC
Primary sclerosing cholangitis with repeated biliary sepsis, or intractable itch, can justify listing under variant syndrome criteria even at a lower UKELD.
-
Metabolic and genetic liver disease
Wilson disease, alpha-1 antitrypsin deficiency, hereditary haemochromatosis with advanced disease, and selected metabolic disorders.
-
Polycystic liver disease
Massive symptomatic hepatomegaly from PLD, where quality of life is severely affected, is a recognised indication under variant syndrome criteria.
-
Red flag: confusion, bleeding, rapid jaundice
New confusion or drowsiness, vomiting blood, or rapidly deepening jaundice can signal acute decompensation or acute liver failure - A&E immediately, not a clinic.
Transplant types
Not every liver transplant is the same operation.
The graft types used in the UK - and which patients each one suits.
-
Whole deceased-donor graft
The commonest UK transplant. A whole liver from a donor after brain death or circulatory death, allocated nationally through the NHSBT transplant benefit score.
-
Split liver graft
One donor liver divided between two recipients - usually a child receiving the left lateral segment and an adult the extended right lobe. It increases the number of transplants per donor.
-
Living-donor liver transplant
A right or left lobe from a healthy, HTA-approved living donor. Rare in UK adults but well established for children, where a parent often donates the left lateral segment.
-
Donation after circulatory death (DCD)
Grafts from donors after circulatory death, an increasing share of UK transplants. Machine perfusion has substantially improved their viability.
-
Auxiliary liver transplant
Part of the native liver is retained and a partial graft implanted alongside - used in acute liver failure where the native liver may recover, allowing immunosuppression to be withdrawn later.
-
Domino liver transplant
A liver removed from a recipient with a metabolic disease is transplanted into another carefully selected recipient, where the metabolic defect will not matter within their lifetime.
-
Normothermic machine perfusion
The donor liver is kept functioning outside the body and assessed before implantation. It has expanded the pool of usable organs considerably in UK centres.
-
Assessment and second opinion only
An honest review of whether referral is warranted at all, or whether the disease is better managed medically for now. Often this is the whole answer.
Safety and recovery
What transplantation actually asks of you.
UK liver transplant results are among the best in the world - roughly 92 per cent survive the first year and around 75 per cent are alive at ten. What people underestimate is the assessment, the waiting, and the lifelong commitment afterwards.
-
Waiting is the hardest part
The median wait for an adult liver in the UK runs to several months, and clinical priority can change. Around 8 to 10 per cent of those listed die or are removed while waiting.
-
Assessment can conclude no
Severe cardiac or pulmonary disease, active malignancy elsewhere, uncontrolled sepsis, or ongoing alcohol or substance misuse can all rule transplantation out. That decision is centre-based, not ours.
-
Lifelong immunosuppression
Tacrolimus-based therapy for life, with regular level monitoring. It brings raised risks of infection, kidney impairment, diabetes, hypertension and skin cancer.
-
Rejection is common and usually treatable
Acute cellular rejection affects roughly a quarter of recipients, most often in the first weeks. It is picked up on bloods and biopsy and usually reversed with steroids.
-
Biliary and vascular complications
Biliary strictures or leaks affect 10 to 15 per cent, and hepatic artery thrombosis a smaller number. Both are managed by the transplant centre, often endoscopically or radiologically.
-
Kidney function after transplant
Calcineurin inhibitors are hard on the kidneys. Renal function is tracked closely and immunosuppression adjusted, sometimes with a second agent added to spare the dose.
-
Alcohol and recurrent disease
Recurrence of the original disease - alcohol-related injury, MASLD, hepatitis B, autoimmune or PSC - is a real long-term risk. Abstinence and metabolic control matter permanently.
-
Skin cancer and lymphoma surveillance
Long-term immunosuppression raises skin cancer risk substantially and lymphoma risk modestly. Sun protection and annual skin checks are lifelong, not optional.
-
Red flags after transplant
Fever, jaundice, dark urine, pale stools, abdominal pain or a sudden rise in liver enzymes - contact the transplant centre immediately, at any hour.
Reading your assessment letter
Your assessment letter in four parts. Read the last one first.
Whether the outcome is referral, active listing or a decision to continue medical management, the letter your hepatologist writes keeps to the same shape.
A quiet reminder
Transplant language is precise and can read coldly - we translate it for you.
If you would like us to talk you through the letter before your next appointment, just ask.
- 01 Header
Diagnosis and disease trajectory
The underlying liver disease, how long it has been present, and what has changed recently - decompensation, tumour, or a rising score.
- 02 Technique
Scores and investigations
UKELD, MELD and Child-Pugh values, the imaging performed, cardiac and respiratory results, and virology and tissue typing where done.
- 03 Findings
Where you sit against the criteria
Whether the UK listing threshold is met, whether a variant syndrome applies, and any factor that would currently count against listing.
- 04 Impression
Referral, timing and what happens next
Read this first: whether referral is being made, to which centre, and what should be optimised in the meantime.
Recognised by major UK insurers
Solid organ transplantation is not covered by UK private medical insurance and is not sold privately - it is delivered exclusively through NHS-designated transplant centres. What insurers do routinely fund is the work that surrounds it: specialist consultations, imaging, cardiac and respiratory assessment and second opinions.
Frequently asked
Everything we get asked about liver transplantation.
Quick answers on eligibility, UK waiting times, why it cannot be bought privately, and what life afterwards looks like.
-
Can I have a liver transplant privately in the UK?
No. All liver transplantation in the United Kingdom takes place in the seven NHS-designated adult transplant centres, with organs allocated nationally by NHS Blood and Transplant according to clinical need and transplant benefit. Under the Human Tissue Act 2004 it is a criminal offence to pay for an organ. Private care can accelerate and strengthen the assessment before referral, but it cannot buy the transplant itself.
-
What is a UKELD score and what is the threshold?
UKELD - the United Kingdom Model for End-stage Liver Disease - is calculated from INR, creatinine, bilirubin and sodium. A score of 49 or above is the standard threshold for listing for elective liver transplantation, corresponding to roughly a nine per cent one-year mortality without transplant. Certain variant syndromes allow listing at lower scores.
-
How long is the wait for a liver in the UK?
It varies with blood group, body size, clinical urgency and the transplant benefit score, but the median wait for an adult runs to several months. Super-urgent listings for acute liver failure are usually transplanted within days. Around 8 to 10 per cent of patients on the elective list die or become too unwell while waiting.
-
What are the survival rates after liver transplant?
UK outcomes are among the best internationally. Roughly 92 per cent of adult recipients are alive at one year, around 85 per cent at five years and about 75 per cent at ten. Outcomes depend heavily on the underlying disease, the recipient’s condition at transplant, and adherence to immunosuppression afterwards.
-
Do I have to be abstinent from alcohol to be considered?
For alcohol-related liver disease, UK centres require a commitment to lifelong abstinence and, in most elective cases, a documented period of abstinence with addiction support in place. The rule is applied thoughtfully rather than mechanically - severe alcohol-related hepatitis is assessed on individual grounds - but abstinence after transplant is non-negotiable.
-
What does the transplant assessment involve?
Several days at a transplant centre: detailed liver imaging, cardiac assessment with echocardiography and often cardiopulmonary exercise testing, lung function, dental and infection screening, virology, tissue typing, and a psychosocial assessment. The case is then presented to the centre listing meeting, which makes the decision collectively.
-
Will I be on medication for the rest of my life?
Yes. Immunosuppression, usually tacrolimus-based and sometimes with mycophenolate or a steroid, continues for life. Doses fall substantially after the first year but never stop. Regular blood monitoring, annual review, and skin and cardiovascular surveillance continue indefinitely.
-
Can a family member donate part of their liver to me?
It is possible but uncommon in UK adults. Living-donor liver transplantation is well established for children, where a parent donates the left lateral segment. Adult-to-adult donation requires a right lobe, carries meaningfully more donor risk, and is performed at only a small number of UK centres. Every living donation requires Human Tissue Authority approval.
-
What happens if I am not accepted for the list?
The centre will explain which factor was decisive - cardiac risk, active malignancy, ongoing substance use, frailty or something else. Some of those are modifiable, and reassessment after a period of optimisation is common. Where transplantation is genuinely not an option, the focus shifts to managing complications and quality of life well.
-
When should I go to A&E rather than book a clinic?
New confusion or drowsiness, vomiting blood, black tarry stools, rapidly deepening jaundice, or fever with cirrhosis all need urgent same-day assessment. After a transplant, any fever, jaundice or sudden abdominal pain means contacting the transplant centre immediately.
Related treatments